Vaccines

Vaccine Recommendation Strategy

Illustrate the value of your product and ensure its inclusion of your product in the national recommendations

Tailored strategy from in-house experts

Securing recommendation for your vaccine requires an understanding of the market and health system dynamics. Work closely with our in-house experts to create a tailored strategy designed to navigate market access efficiently and gaining the recommendations to make your product available to patients.

The right strategy drives timing, access, and profitability, and helps you to protect the patients’ lives more effectively.

Why choose Alira Health?

When it comes to strategic planning, you’ll benefit from our:

  • Ability to gain full understanding of your products’ value and to effectively incorporate it into the recommendation strategy
  • Focused attention on your specific needs and individual aspects of your vaccine
  • In-house industry experts with over 25 years of experience working with the key market stakeholders—from payers to doctors
  • In-depth knowledge of industry challenges—and how to meet them

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Bernd Schollmeier
Bernd Shollmier
Vice President of Global Market Access Vaccines
We are seeing a lot of traction in the industry, as well as interest in vaccine production. To support companies in a challenging payer environment, we created a dedicated vaccine division in our Global Market Access department to provide a variety of solutions that maximize patient access and the gross-to-net value of the product across the full product lifecycle.

Related News

Events January 27, 2023
Alira Health and Biocat Startup Support Program Presentation
Biocat and Alira Health partnered to foster Market Access for startups. Alira Health, a global healthcare advisory and technology company, and Biocat, a strategic stakeholder building(...)
Market Access Startups
Publications January 20, 2023
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Market Access Medical Devices Pharma
Publications January 19, 2023
Medical Device Regulation in 2023: A Window of Opportunity
We spoke with our team of regulatory experts about the recent news regarding the MDR and the opportunity it presents to device manufacturers in 2023.
Medical Devices MedTech Regulatory
Publications January 19, 2023
What’s Next for Diabetes: Patient Engagement, Personalization, and Usable Technology
Alira Health partnered with the ADA to support this conversation and explore the most important topics emerging from patients, physicians, specialists, and patient advocates including(...)
Clinical Trials Diabetes MedTech Patient Engagement
Publications January 17, 2023
Insights on the MedTech Industry
In 2023, the MedTech industry will seek to turn the challenges of disruption into opportunities for lasting transformation. Discover the three keys that a successful MedTech company(...)
Healthcare Technology MedTech Patient Engagement
Events January 11, 2023
MD&M West 2023
Join our colleague Carlo Stimamiglio for his presentation “MedTech CDMO: Market and M&A Trends in 2023”, as he goes over key takeaways from our upcoming 2023 US MedTech CDMO Report.
CDMO MedTech
Publications December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.